alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Devin Lee BASS, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s)

CASE NO.: 1D14-2449

District Court of Appeal of Florida, First District.

February 22, 2019

ORDER ON MOTIONS FOR REHEARING AND REHEARING EN BANC

BY ORDER OF THE COURT:

Neither the motion for rehearing nor Judge Makar's latest dissent on the merits identifies points of law or fact that the court has overlooked or misapprehended. Therefore, the January 7, 2019 motions for rehearing and rehearing en banc are denied.

Ray and Winsor, JJ., concur.

Makar, J., dissenting from denial of rehearing and rehearing en banc.

Confusion and conflict. That's what now exists in this district because the panel's decision parts ways with precedent, including *M.M. v. State* , 51 So.3d 614 (Fla. 1st DCA 2011), as Bass's motions for rehearing and rehearing en banc persuasively demonstrate. The panel majority holds that a person's failure to give a correct name to a law enforcement officer constitutes the crime of obstruction under section 843.02, Florida Statutes, whether the person was lawfully detained or not. According to the majority, Bass could have been a suspect in lawful custody, a potential witness, or a mere passerby or onlooker at the time of his fib. Doesn't matter: he gave an incorrect name (which, by the way, didn't fool the officer or hinder his investigation) and thereby committed the crime of obstruction. But wait. *M.M.* says that under section 843.02, "failing to give one's *correct identity* is not a crime *unless the person is legally detained* ." 51 So.3d at 616 (emphasis added). Bass, too, failed to give a *correct identity* , but the majority says it is a crime because "it does not matter" whether he was legally detained or not. It's a head scratcher how this case and *M.M.* can cohabitate in the same district. This case also butts heads with our sibling courts. Direct and irreconcilable conflict now exists with districts that have held no criminal liability attaches for giving a false name (or failing to give a correct identity) unless done while lawfully detained; even the State sides with Bass on this point, saying it "agrees that the Second District Court of Appeal's holding in *Sauz v. State* , 27 So.3d 226 (Fla. 2d DCA 2010) [,] that legal detention is required" in this case. That's been the standard statewide, one from which the panel decision departs. Because of the express and direct conflict that now exists, our *389supreme court ought to clear up this newly-created muddle.

**I HEREBY CERTIFY** that the foregoing is (a true copy of) the original court order.
# C_2023235EN.01003201.xml

| 3.7.2023 | EN | Official Journal of the European Union | C 235/32 |
| --- | --- | --- | --- |

3.7.2023

EN

Official Journal of the European Union

C 235/32

---

Judgment of the General Court of 24 May 2023 — Meta Platforms Ireland v Commission

(Case T-452/20) (1)

(Competition - Data market - Administrative procedure - Article 18(3) and Article 24(1)(d) of Regulation (EC) No 1/2003 - Request for information - Virtual data room - Obligation to state reasons - Legal certainty - Rights of the defence - Necessity of the information requested - Misuse of powers - Right to privacy - Proportionality - Principle of good administration - Professional secrecy)

(2023/C 235/41)

Language of the case: English

Parties

Applicant: Meta Platforms Ireland Ltd, formerly Facebook Ireland Ltd (Dublin, Ireland) (represented by: D. Jowell KC, D. Bailey, Barrister, J. Aitken, D. Das, S. Malhi, R. Haria, M. Quayle, Solicitors, and T. Oeyen, lawyer)

Defendant: European Commission (represented by: G. Conte, C. Urraca Caviedes and C. Sjödin, acting as Agents)

Intervener in support of the defendant: Federal Republic of Germany (represented by: S. Costanzo, acting as Agent)

Re:

By its action under Article 263 TFEU, the applicant seeks annulment of Commission Decision C(2020) 3013 final of 4 May 2020 relating to a proceeding under Article 18(3) and Article 24(1)(d) of Council Regulation (EC) No 1/2003 (Case AT.40684 — Facebook Marketplace), as amended by Commission Decision C(2020) 9229 final of 11 December 2020.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Meta Platforms Ireland Ltd to bear its own costs and to pay those incurred by the European Commission, including those incurred in the proceedings for interim relief; |
| --- | --- |

2.

Orders Meta Platforms Ireland Ltd to bear its own costs and to pay those incurred by the European Commission, including those incurred in the proceedings for interim relief;

| 3. | Orders the Federal Republic of Germany to bear its own costs. |
| --- | --- |

3.

Orders the Federal Republic of Germany to bear its own costs.

---

(1)  OJ C 287, 31.8.2020.

---
C.M. v. JEFFERSON COUNTY DEPARTMENT OF HUMAN RESOURCES

2160422

Court of Civil Appeals of Alabama.

September 8, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
JOHN G. WALTON CONSTRUCTION CO. v. Michael E. STRICKLIN

2160383

Court of Civil Appeals of Alabama.

July 17, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 661 Agreed to Senate (ATS)]

<DOC>

118th CONGRESS
  2d Session
S. RES. 661

Designating the week of April 15 through April 21, 2024, as ``National 
                      Osteopathic Medicine Week''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 23, 2024

 Mr. Manchin (for himself, Mr. Wicker, Mr. Heinrich, Mrs. Capito, and 
Mr. Risch) submitted the following resolution; which was considered and 
                               agreed to

_______________________________________________________________________

                               RESOLUTION

 
Designating the week of April 15 through April 21, 2024, as ``National 
                      Osteopathic Medicine Week''.

Whereas there are more than 148,000 osteopathic physicians and 38,000 
        osteopathic medical students in the United States ;
Whereas osteopathic physicians and medical students train at high-caliber 
        schools of osteopathic medicine across the United States, including in 
        rural communities;
Whereas osteopathic physicians have made significant contributions to the 
        healthcare system of the United States since the founding of osteopathic 
        medicine in 1892;
Whereas the number of osteopathic physicians in the United States has increased 
        by more than 30 percent in the past 5 years;
Whereas osteopathic medicine emphasizes a whole-person, patient-centric approach 
        to healthcare, and osteopathic physicians play an important role in the 
        healthcare system of the United States;
Whereas osteopathic physicians play a critical role in public health 
        preparedness and work on the front lines treating patients;
Whereas osteopathic physicians train and practice in all medical specialties and 
        practice settings;
Whereas osteopathic physicians and medical students in the United States are 
        dedicated to improving the health of their communities through efforts 
        to increase education and awareness and by delivering high-quality 
        health services; and
Whereas osteopathic physicians practice in every State: Now, therefore, be it
    Resolved, That the Senate--
            (1) designates the week of April 15 through April 21, 2024, 
        as ``National Osteopathic Medicine Week'';
            (2) recognizes the contributions of osteopathic physicians 
        to the healthcare system of the United States; and
            (3) celebrates the role that colleges of osteopathic 
        medicine play in training the next generation of physicians.
                                 <all>
```
<PAGE>

                                                                    EXHIBIT 99.4

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             As Adopted Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

              In connection with the Annual Report and Transition Report on Form
20-F of Silverline Technologies Limited (the "Company") for the fiscal year
ended March 31, 2002, and the transition period from April 1, 2002 to June 30,
2002, as filed with the Securities and Exchange Commission on the date hereof,
I, Krishna K. Subramanian, Executive for International Initiatives and Acting
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. (S)1350,
as adopted pursuant to (S)302 of the Sarbanes-Oxley Act of 2002, that:

         1.   I have reviewed this annual report and transition report on Form
20-F of Silverline Technologies Limited;

         2.   Based on my knowledge, this annual report and transition report
does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect
to the period covered by this annual report and transition report ; and

         3.   Based on my knowledge, the financial statements, and other
financial information included in this annual report and transition report,
fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods
presented in this annual report and transition report.

Dated:  February 15, 2003            By:   /s/ Krishna K. Subramanian
                                         ---------------------------------------
                                         Krishna K. Subramanian
                                         Acting Chief Financial Officer and
                                         Executive for International Initiatives

         This certification accompanies this Annual Report and Transition Report
on Form 20-F pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and shall
not, except to the extent required by such Act, be deemed filed by the Company
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
<PAGE>

                                                                    EXHIBIT 99.1


                        Certification of CEO Pursuant to
                             18 U.S.C. Section 1350,
                             As Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002



     In connection with the Annual Report of Xtreme Companies, Inc.(the
"Company")on Form 10-K for the period ending December 31, 2002 as filed with the
Securities and Exchange Commission on March 31, 2003 (the "Report"), Donald
Bradley Executive Officer of the Company, hereby certifies, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of his knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.



                                              /s/ Donald C. Bradley
                                            ------------------------------------

                                            Chief Executive Officer
April 14, 2003

This certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been
provided to U.S. Energy and will be retained by Xtreme Companies, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request."


                        Certification of CFO Pursuant to
                             18 U.S.C. Section 1350,
                             As Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002


     In connection with the Annual Report of Xtreme Companies, Inc.(the
"Company") on Form 10-K for the period ending December 31, 2002 as filed with
the Securities and Exchange Commission on March 31, 2003 (the "Report"), Richard
Scoble, Chief Financial Officer of the Company, hereby certifies, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of his knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.




                                             /s/ Richard Scoble
                                            ------------------------------------
                                            Chief Financial Officer
April 14, 2003

This certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
EXHIBIT 32.1


                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of United Energy Corp. (the
"Company") on Form 10-Q/A for the period ending June 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Ronald
Wilen, Chairman and Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

     (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


Dated:  July 29, 2004        By: /s/ Ronald Wilen
                              ------------------
                                     Ronald Wilen
                                     Chairman and Chief Executive Officer


This certification accompanies this Report on Form 10-Q/A pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent
required by such Act, be deemed filed by the Company for purposes of Section 18
of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form with the electronic version of this written statement
required by Section 906, has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.
# C_2020297EN.01002901.xml

| 7.9.2020 | EN | Official Journal of the European Union | C 297/29 |
| --- | --- | --- | --- |

7.9.2020

EN

Official Journal of the European Union

C 297/29

---

Request for a preliminary ruling from the Hof van beroep te Brussel (Belgium) lodged on 9 June 2020 — Impexeco NV v Novartis AG

(Case C-253/20)

(2020/C 297/39)

Language of the case: Dutch

Referring court

Hof van beroep te Brussel

Parties to the main proceedings

Appellant: Impexeco NV

Respondent: Novartis AG

Questions referred

| 1. | Must Articles 34 to 36 TFEU be interpreted as meaning that, where a branded medicine (reference medicine) and a generic medicine have been put on the market in the EEA by economically linked undertakings, a trade mark proprietor’s opposition to the further commercialisation of the generic medicine by a parallel importer after the repackaging of that generic medicine by the affixing to it of the trade mark of the branded medicine (reference medicine) in the country of importation may lead to an artificial partitioning of the markets of the Member States? |
| --- | --- |

1.

Must Articles 34 to 36 TFEU be interpreted as meaning that, where a branded medicine (reference medicine) and a generic medicine have been put on the market in the EEA by economically linked undertakings, a trade mark proprietor’s opposition to the further commercialisation of the generic medicine by a parallel importer after the repackaging of that generic medicine by the affixing to it of the trade mark of the branded medicine (reference medicine) in the country of importation may lead to an artificial partitioning of the markets of the Member States?

| 2. | If the answer to that question is in the affirmative, must the trade mark proprietor’s opposition to that rebranding be assessed by reference to the BMS conditions? |
| --- | --- |

2.

If the answer to that question is in the affirmative, must the trade mark proprietor’s opposition to that rebranding be assessed by reference to the BMS conditions?

| 3. | Is it relevant to the answer to those questions that the generic medicine and the branded medicine (reference medicine) are identical or have the same therapeutic effect as referred to in Article 3(2) of the Koninklijk besluit van 19 april 2001 inzake parallelinvoer (Royal Decree of 19 April 2001 on parallel imports)? |
| --- | --- |

3.

Is it relevant to the answer to those questions that the generic medicine and the branded medicine (reference medicine) are identical or have the same therapeutic effect as referred to in Article 3(2) of the Koninklijk besluit van 19 april 2001 inzake parallelinvoer (Royal Decree of 19 April 2001 on parallel imports)?

---
III 

118TH CONGRESS 

2D SESSION S. RES. 660 

Supporting the goals and ideals of National Public Safety Telecommunicators 

Week. 

IN THE SENATE OF THE UNITED STATES 

APRIL 19, 2024 

Ms. KLOBUCHAR (for herself and Mr. BUDD) submitted the following resolution; which was referred to the Committee on Commerce, Science, and 

Transportation 

RESOLUTION 

Supporting the goals and ideals of National Public Safety 

Telecommunicators Week. 

Whereas public safety telecommunications professionals play 

a critical role in emergency response; 

Whereas the work that public safety telecommunications professionals perform goes far beyond simply relaying information between the public and first responders; 

Whereas, when responding to reports of missing, abducted, 

and sexually exploited children, the information obtained 

and actions taken by public safety telecommunications 

professionals form the foundation for an effective response; 

Whereas, when a hostage taker or suicidal individual calls 

911, the first contact that individual has is with a public 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•SRES 660 IS 

safety telecommunications professional, whose negotiation 

skills can prevent the situation from worsening; 

Whereas, during crises, public safety telecommunications professionals, while collecting vital information to provide 

situational awareness for responding officers— 

(1) coach callers through first aid techniques; and 

(2) give advice to those callers to prevent further 

harm; 

Whereas the work done by individuals who serve as public 

safety telecommunications professionals has an extreme 

emotional and physical toll on those individuals, which is 

compounded by long hours and the around-the-clock nature of the job; 

Whereas public safety telecommunications professionals 

should be recognized by all levels of government for the 

lifesaving and protective nature of their work; 

Whereas major emergencies and natural disasters highlight 

the dedication of public safety telecommunications professionals and their important work in protecting the public 

and police, fire, and emergency medical officials; and 

Whereas public safety telecommunications professionals are 

often called as witnesses to provide important testimony 

in criminal trials: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) recognizes the week of April 14 through 20, 

3 2024, as ‘‘National Public Safety Telecommunica4 tors Week’’; 

5 (2) supports the goals and ideals of National 

6 Public Safety Telecommunicators Week; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•SRES 660 IS 

1 (3) honors and recognizes the important and 

2 lifesaving contributions of public safety tele3 communications professionals in the United States; 

4 and 

5 (4) encourages the people of the United States 

6 to remember the value of the work performed by 

7 public safety telecommunications professionals. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
# C_2023007EN.01000401.xml

| 9.1.2023 | EN | Official Journal of the European Union | C 7/4 |
| --- | --- | --- | --- |

9.1.2023

EN

Official Journal of the European Union

C 7/4

---

Judgment of the Court (First Chamber) of 10 November 2022 — European Commission v Valencia Club de Fútbol, SAD, Kingdom of Spain

(Case C-211/20 P) (1)

(Appeal - State aid - Public guarantee granted by a public entity - Loans to three football clubs from the Community of Valencia (Valencia CF, Hércules CF and Elche CF) - Decision declaring the aid to be incompatible with the internal market - Annulment of the decision in so far as it concerns Valencia CF - Concept of ‘advantage’ - Assessment of the existence of an advantage - Guarantee Notice - Interpretation - Duty of care on the part of the European Commission - Burden of proof - Distortion)

(2023/C 7/04)

Language of the case: Spanish

Parties

Appellant: European Commission (represented by G. Luengo, P. Němečková and B. Stromsky, acting as Agents)

Other parties to the proceedings: Valencia Club de Fútbol SAD (represented by G. Cabrera López, J.R. García-Gallardo Gil-Fournier and D. López Rus, abogados), Kingdom of Spain (represented by M.J. Ruiz Sánchez, acting as Agent)

Operative part of the judgment

The Court:

| 1. | Dismisses the appeal; |
| --- | --- |

1.

Dismisses the appeal;

| 2. | Orders the European Commission to bear its own costs and to pay those incurred by Valencia Club de Fútbol SAD; |
| --- | --- |

2.

Orders the European Commission to bear its own costs and to pay those incurred by Valencia Club de Fútbol SAD;

| 3. | Orders the Kingdom of Spain to bear its own costs. |
| --- | --- |

3.

Orders the Kingdom of Spain to bear its own costs.

---

(1)  OJ C 262, 10.8.2020.

---
Eddie RIVERA, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D18-3030

District Court of Appeal of Florida, Second District.

March 19, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.